Vol 4, No 2 (2018)
Review paper
Published online: 2018-06-20
Preparation for pregnancy and delivery of patient with an inflammatory joint disease
Forum Reumatol 2018;4(2):95-101.
Abstract
Zaplanowanie i właściwe przygotowanie do ciąży kobiety obciążonej chorobą reumatyczną jest konieczne. Skutkuje to redukcją odsetka nieplanowanych ciąż i zwiększa szansę na pomyślny przebieg i zakończenie ciąży. W prezentowanej pracy, na podstawie danych z literatury, omówiono zagadnienia dotyczące odpowiedniego przygotowania chorej do ciąży, wskazań do wykonania cięcia cesarskiego oraz trudności związane z chorobą reumatyczną, jakie może napotkać anestezjolog podczas znieczulenia podczas porodu. Powyższe zagadnienia odniesiono do pacjentek chorych na reumatoidalne zapalnie stawów i spondyloartropatie ze względu na ich najczęstsze występowanie w naszej codziennej praktyce.
Forum Reumatol. 2018, tom 4, nr 2: 95–101
Keywords: zapalenie stawówciążaprzygotowanie
References
- de Man YA, Dolhain RJ, van de Geijn FE, et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008; 59(9): 1241–1248.
- Wallenius M, Skomsvoll JF, Irgens LM, et al. Fertility in women with chronic inflammatory arthritides. Rheumatology (Oxford). 2011; 50(6): 1162–1167.
- Pouchot J, Le Parc JM, Queffelec L, et al. Association Française des Polyarthritiques. Perceptions in 7700 patients with rheumatoid arthritis compared to their families and physicians. Joint Bone Spine. 2007; 74(6): 622–626.
- Ostensen M, Wallenius M. Rheumatoid Arthritis and Seronegative Spondyloartropathy. . In: Sammaritano L, Bermans L. ed. Contraception and Pregnancy in Patients with Rheumatic Disease. Springer 2014: 140, 151–153.
- Ostensen M, Brucato A, Carp H. Treatment with immunosuppressive and disease modifying drugs during pregnancy aPregnancy and reproduction in autoimmune rheumatic deseases.nd lactation. Rheumatology. 2011; 50: 658–659.
- Østensen M, Fuhrer L, Mathieu R, et al. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis. 2004; 63(10): 1212–1217.
- Ostensen M, Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 1983; 26(9): 1155–1159.
- Gregory K, Niembyl J, Johnsos T. Ciągłość opieki przedkoncepcyjnej i prenatalnej. In: Gabbe S, Niebyl J, Simpson J. ed. Położnictwo ciąża prawidłowa i powikłana. Elsevier Urban and Partner, Wrocław 2014: 107–133.
- Chandler AL, Hobbs CA, Mosley BS, et al. National Birth Defects Prevention Study. Neural tube defects and maternal intake of micronutrients related to one-carbon metabolism or antioxidant activity. Birth Defects Res A Clin Mol Teratol. 2012; 94(11): 864–874.
- Wallenius M, Ostensen M. Rheumatoid Arthritis and seronegative Spondyloartropathy. In: Sammaritano L, Bermans L. ed. Contraception and Pregnancy in Patients with Rheumatic Disease. Springer 2014: 152.
- Sammaritano L, Bermas B. General Approach: Pre-pregnancy Assesment of the Rheumatic Disease Patient.. In: Sammaritano L, Bermans L. ed. Contraception and Pregnancy in Patients with Rheumatic Disease. Springer 2014: 65–70.
- Jesam C, Salvatierra AM, Schwartz JL, et al. Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial. Contraception. 2014; 90(2): 168–173.
- Chan LY, Yuen PM. Risk of miscarriage in pregnant users of NSAIDs. More information is needed to be able to interpret study's results. BMJ. 2001; 322(7298): 1365–1366.
- Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003; 327(7411): 368.
- Clowse MEB, Wolf DC, Förger F, et al. Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol. J Rheumatol. 2015; 42(12): 2270–2278.
- Bazzani C, Scrivo R, Andreoli L, et al. Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study. Clin Exp Rheumatol. 2015; 33(5): 688–693.
- Vermillion ST, Scardo JA, Lashus AG, et al. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol. 1997; 177(2): 256–9; discussion 259.
- Samanta R, Shoukrey K, Griffiths R. Rheumatoid arthritis and anaesthesia. Anaesthesia. 2011; 66(12): 1146–1159.
- Practice Guidelines for Obstetric Anesthesia: An Updated Report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology. Anesthesiology. 2016; 124(2): 270–300.
- Reynolds RM, Stewart PM, Seckl JR, et al. Assessing the HPA axis in patients with pituitary disease: a UK survey. Clin Endocrinol (Oxf). 2006; 64(1): 82–85.
- Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, et al. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study. Rheumatology (Oxford). 2014; 53(4): 757–763.
- Brouwer J, Laven JSE, Hazes JMW, et al. Levels of serum anti-Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013; 65(9): 1534–1538.
- Weber-Schoendorfer C, Chambers C, Wacker E, et al. Network of French Pharmacovigilance Centers. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol. 2014; 66(5): 1101–1110.
- Cassina M, Johnson DL, Robinson LK, et al. Organization of Teratology Information Specialists Collaborative Research Group. Pregnancy outcome in women exposed to leflunomide before or during pregnancy. Arthritis Rheum. 2012; 64(7): 2085–2094.
- Chambers CD, Johnson DL, Robinson LK, et al. Organization of Teratology Information Specialists Collaborative Research Group. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum. 2010; 62(5): 1494–1503.
- Riley SA, Lecarpentier J, Mani V, et al. Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution. Gut. 1987; 28(8): 1008–1012.
- Motta M, Tincani A, Faden D, et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol. 2005; 25(2): 86–89.
- Mok CC, Chan PT, To CH. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus. Arthritis Rheum. 2013; 65(1): 206–210.
- Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011; 183(7): 796–804.
- Ross G, Sammaritano L, Nass R, et al. Corticosteroids during pregnancy. Scand J Rheumatol Suppl. 1998; 107(4): 136–138.
- Litwiniuk M, Niwińska A. Macierzyństwo kobiet leczonych wcześniej z powodu raka piersi. Onkologia w Praktyce Klinicznej. 2003; 3: 23–27.
